Viking Therapeutics VKTX
NASDAQ VKTX
$24.40 -1.43 (-5.54%)
At close: Oct 23, 2026 · 4:00 PM EDT

Viking Therapeutics (VKTX) Cash from Investing Activities (2015 - 2026)

Updated

Viking Therapeutics (VKTX) reported Cash from Investing Activities of $109.43 million for Q2 2026, up 157.4% from $42.51 million a year earlier and up 101.9% from the prior quarter.

Analysis

Viking Therapeutics (VKTX) Cash from Investing Activities (2015 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Viking Therapeutics' Cash from Investing Activities came in at $399.26 million, up 188.8% year-over-year; for FY2025, it was $341.39 million.

  • Cash from Investing Activities has a five-year compound annual growth rate of 52.4% (FY2020 to FY2025).
  • By year, Cash from Investing Activities came in at -$553.37 million in FY2024, -$179.09 million in FY2023, $54.75 million in FY2022 (+44.2%) and $37.96 million in FY2021 (-8.7%).
  • Five-year quarterly Cash from Investing Activities spans a low of -$459.79 million in Q1 2024 and a high of $160.03 million in Q3 2025.
  • Year over year, Cash from Investing Activities gained in two of the last four quarters, with growth averaging 144.8%.
  • The high point for year-over-year Cash from Investing Activities in five years was Q3 2025 (growth of 517.8%); the low point was Q4 2024 (a decline of 81.6%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $54.19 million (Q1 2026), $75.61 million (Q4 2025) and $160.03 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -15.40 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn -2.71 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -1.20 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn -5.60 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn -3.11 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -2.91 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -569.00 Mn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -10.35 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.11 Bn
10 Viking Therapeutics 2.85 Bn 321.40 Mn - 109.43 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 109.43 Mn
Mar 31, 2026 54.19 Mn
Dec 31, 2025 75.61 Mn
Sep 30, 2025 160.03 Mn
Jun 30, 2025 42.51 Mn
Mar 31, 2025 63.25 Mn
Dec 31, 2024 6.58 Mn
Sep 30, 2024 25.90 Mn
Jun 30, 2024 -126.06 Mn
Mar 31, 2024 -459.79 Mn
Dec 31, 2023 35.73 Mn
Sep 30, 2023 -12.53 Mn
Jun 30, 2023 -204.48 Mn
Mar 31, 2023 2.20 Mn
Dec 31, 2022 7.26 Mn
Sep 30, 2022 26.89 Mn
Jun 30, 2022 18.98 Mn
Mar 31, 2022 1.62 Mn
Dec 31, 2021 27.41 Mn
Sep 30, 2021 13.62 Mn
API Access

Viking Therapeutics Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=VKTX&period=max&api_key=YOUR_API_KEY